Oligonucleotide Testing Market

Your Catalyst To a Lucrative Business
Oligonucleotide Testing Market Analysis, Size, Share, Growth,
Industry Trends and Forecast to 2024 | Hexa Research
“Oligonucleotide Testing Market is expected to
witness a significant growth, pertaining to the rise
in the technological advancements in synthesis of
oligonucleotide products.
29 November 2018, The global Oligonucleotide Testing Market to reach USD 1,746.52 million by 2024, owing
to the increasing research and development activities in the field of oligonucleotide. For instance, nowadays,
multifunctional oligonucleotide based aptamer molecules are widely studied biomedical class among
scientists across the globe. Due to its unique chemistry and potential advantages compared to currently
available drugs (i.e. antibodies), aptamer became one of the most budding market for the future period.
With the rising concept of oligonucleotide as diagnostic, research and therapeutic agent, it is noticed that
companies investigating the potential of oligonucleotide is going up. Number of small companies or start -ups
entering the market is continuously increasing due to its potential advantages. Over th e past few years, there
has been explosive growth in number of research article published in the area of oligonucleotide and its
products.
Browse Details of Report @ https://www.hexaresearch.com/research-report/oligonucleotide-testingmarket
Follow Us:
Your Catalyst To a Lucrative Business
According to the open access journal Multidisciplinary Digital Publishing Institute (MDPI AG), in 1995, there
were not more than 200 research articles on aptamers. Compare to this, now it is around 1800 research
literatures published by scientist on aptamer assays or therapeutics. This number indicates that companies
focusing on the oligonucleotide drugs is rising every year. This fact would in turn cause a surge in demand for
oligonucleotide testing services, augmenting growth. However, strict regulatory framework is anticipated to
hamper the market expansion to some extent.
Types segment is categorized into Instrument, Software, and Services. Among which, instrument segment
captured the largest share of the total market. Introduction of technological advanced chromatographic
columns coupled with increasing demand for oligonucleotide synthesis drive the segment growth. Instrument
segment is further divided into liquid chromatography, mass chromatography and capillary electrophoresis.
In terms of application, the market is segmented as research and commercial. Research segment capture the
largest share owing to the strong product pipeline.
In 2016, North America dominated the market contributing a share of more than 40% in the revenue
generated worldwide. The primary reason being the high growth of this region, particularly in the U.S. is the
rising research and development activities on oligonucleotides. Asia pacific region was esti mated to be the
fastest growing region in the global market and is anticipated to grow at a CAGR of about 10.8% by 2024. The
growing need for effective therapeutics, rising awareness level, coupled with the favorable government
initiatives are expected to drive growth in this region.
Currently there are very less approved oligonucleotide drugs namely fomivirsen (Vitravene), pegaptanib
(Macugen), and mipomersen (Kynamro). Of which mipomersen and fomivirsen acti through RNase H
mediated cleavage of targeted RNA. These drugs were developed by Ionis Pharmaceuticals. As the number of
drugs available in the market are less, the oligonucleotide pipeline is strong and is expected to show positive
response over the projection period.
Technological advances in development of oligonucleotide products has been one of the major market driver.
Oligonucleotide synthesis has undergone tremendous changes which has resulted in rapid synthesis and cost effective techniques of oligomer synthesis. Improvement of synthesis methods which include high
throughput synthesizers, better coupling reagents and new sets of protective amino groups has drastically
changed the nucleotide synthesis chemistry. With rapid development in oligonucleotide synthesis, the testing
market is also expected to show lucrative growth. The major players are focusing on quality, service and
innovation and adopting strategies such as product portfolio expansion, capacity expansions, and
development of new facilities to gain market share.
Follow Us:
Your Catalyst To a Lucrative Business
Hexa Research has segmented the global oligonucleotide testing market report based on product type,
application and region:
Segmentation by Type, 2014 - 2024
• Instrument
• Liquid Chromatography
• Mass Chromatography
• Capillary Electrophoresis
• Software
• Service
Segmentation by application, 2014 - 2024
• Research
• Commercial
Segmentation by region, 2014 - 2024
• North America
• U.S.
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Rest of the world (RoW)
Key players analyzed:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Integrated DNA Technologies, Inc.
• Agilent Technologies
• Bruker
Browse Related Category Market Reports @ https://www.hexaresearch.com/researchcategory/pharmaceuticals-industry
Follow Us:
Your Catalyst To a Lucrative Business
Table of Content of Oligonucleotide Testing Market
Chapter 1. Executive Summary
Chapter 2. Methodology and Scope
2.1. Research methodology
2.2. Assumptions
2.3. List of data sources
Chapter 3. Introduction
3.1. Research scope & market segmentation
Chapter 4. Oligonucleotide Testing Market Trends: Drivers & Opportunities
4.1. Key industry trends
4.1.1. Market drivers
4.1.2. Market Restraints
4.2. Supply chain analysis
4.3. Porter's Five Forces’ analysis
Chapter 5. Oligonucleotide Testing Market, By Type
5.1. Global oligonucleotide testing market movement, by type, 2016 & 2024
5.1.1. Instrument
5.1.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.1.1.1.1. Liquid chromatography
5.1.1.1.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.1.1.1.2. Mass chromatography
5.1.1.1.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.1.1.1.3. Capillary electrophoresis
5.1.1.1.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.1.2. Software
5.1.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
5.1.3. Service
5.1.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
Chapter 6. Oligonucleotide Testing Market Trends, By Application
6.1. Global oligonucleotide testing market movement, by application, 2016 & 2024
Follow Us:
Your Catalyst To a Lucrative Business
6.1.1. Research
6.1.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
6.1.2. Commercial
6.1.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
Chapter 7. Oligonucleotide Testing Market Trends, By Region
7.1. Global oligonucleotide testing market movement, by region, 2016 & 2024
7.1.1. North America
7.1.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.1.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.1.3. Market estimates and forecast, by application, 2014 - 2024 (USD Million)
7.1.2. Europe
7.1.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.2.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.2.3. Market estimates and forecast, by application, 2014 - 2024 (USD Million)
7.1.3. Asia Pacific
7.1.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.3.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.3.3. Market estimates and forecast, by application, 2014 - 2024 (USD Million)
7.1.4. Rest of the World (RoW)
7.1.4.1. Market estimates and forecast, 2014 - 2024 (USD Million)
7.1.4.2. Market estimates and forecast, by type, 2014 - 2024 (USD Million)
7.1.4.3. Market estimates and forecast, by application, 2014 - 2024 (USD Million)
Chapter 8. Key Country Markets
8.1. U.S.
8.1.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.2. Germany
8.2.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.3. U.K
8.3.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.4. China
8.4.1. Market estimates and forecast, 2014 - 2024 (USD Million)
8.5. India
8.5.1. Market estimates and forecast, 2014 - 2024 (USD Million)
Follow Us:
Your Catalyst To a Lucrative Business
Chapter 9. Competitive Landscape
9.1. Company market share analysis
9.2. Strategic framework
9.3. Company profiles
9.3.1. Thermo Fisher Scientific Inc.
9.3.1.1. Company Overview
9.3.1.2. Product Benchmarking
9.3.1.3. Financial Performance
9.3.1.4. Recent Initiatives
9.3.2. Merck KGaA
9.3.2.1. Company Overview
9.3.2.2. Product Benchmarking
9.3.2.3. Financial Performance
9.3.2.4. Recent Initiatives
9.3.3. Integrated DNA Technologies, Inc.
9.3.3.1. Company Overview
9.3.3.2. Product Benchmarking
9.3.3.3. Financial Performance
9.3.3.4. Recent Initiatives
9.3.4. Agilent Technologies
9.3.4.1. Company Overview
9.3.4.2. Product Benchmarking
9.3.4.3. Financial Performance
9.3.4.4. Recent Initiatives
9.3.5. Bruker
9.3.5.1. Company Overview
9.3.5.2. Product Benchmarking
9.3.5.3. Financial Performance
9.3.5.4. Recent Initiatives
9.3.6. List of other vendors
Follow Us:
Your Catalyst To a Lucrative Business
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - https://www.hexaresearch.com
Follow Us:

The global oligonucleotide testing market to reach USD 1,746.52 million by 2024, owing to the increasing research and development activities in the field of oligonucleotide.

Download Report